REDHAWK IN TALKS TO POTENTIALLY ACQUIRE OKLAHOMA CANNABIS ASSETS
REDHAWK IN TALKS TO POTENTIALLY
OKLAHOMA CANNABIS ASSETS
Completion of Any Acquisition
Remains Subject to, Among Other Things,
the Negotiation and Execution of a
Definitive Agreement and Satisfaction
of Closing Conditions
LA -- August
21, 2020 --
InvestorsHub NewsWire -- RedHawk Holdings
SNDD) ("RedHawk" or the
"Company"), a diversified holding
company primarily engaged in sales and
distribution of medical devices, announced today
its wholly-owned subsidiary,
RedHawk Pharma, LLC, has been in discussions
to potentially acquire certain cannabis assets
including licenses to grow, manufacture and sell in the
Oklahoma, with an anticipated initial focus on "craft"
cultivation and distribution of product.
anticipates a short but comprehensive due diligence
period. A closing, if any, is expected to occur before December 31,
upon, among other
things, approval by RedHawk's board of directors, the negotiation,
acceptance and execution of a final definitive purchase agreement,
acceptance and approval by the board of directors and
the shareholders of
of legal and financial due diligence, RedHawk obtaining the
required amount of acquisition financing, and the obtainment of
and approvals of
any third parties.
RedHawk cannot provide any assurance that a
agreement will be reached on acceptable terms or at
due diligence will be satisfactory, that the required acquisition
financing will be obtained by RedHawk on acceptable terms or at
all, or that the acquisition
will ultimately be completed
any particular time
frame or at all.
# # #
About RedHawk Holdings Corp.
RedHawk Holdings Corp. is a diversified holding company which,
through its subsidiaries, is engaged in the sales
and distribution of medical devices, sales
of branded generic pharmaceutical drugs,
commercial real estate investment and leasing,
sales of point of entry full-body security systems,
and specialized financial services. Through its
medical products business unit, the Company sells
the Sharps and Needle Destruction Device
(SANDD™), WoundClot Surgical - Advanced Bleeding
Control, and the Carotid Artery
Digital Non-Contact Thermometer. Through our
United Kingdom based subsidiary, we manufacture and market branded
generic pharmaceuticals. RedHawk Energy holds the
exclusive U.S. manufacturing and distribution rights for the Centri
Controlled Entry System, a unique, closed cabinet, nominal dose
transmission full-body x-ray scanner. For more
information, please visit: http://www.redhawkholdingscorp.com
Cautionary Statement Regarding Forward-Looking
This release may contain forward-looking statements.
Forward-looking statements are all statements other than statements
of historical fact. Statements contained in this release that are
not historical facts may be deemed to be forward-looking
statements. The words "anticipate," "may," "can," "plans,"
"believes," "estimates," "expects," "projects," "targets,"
"intends," "likely," "will," "should," "to be,"
"potential" and any similar expressions are intended to identify
those assertions as forward-looking statements.
Investors are cautioned that forward-looking statements are
inherently uncertain. Actual performance and results,
including any potential completion of the
acquisition of the cannabis assets described
herein, may differ materially from that projected or
suggested herein due to certain risks and uncertainties
including, but not limited to, the
negotiation, acceptance and execution of a final
definitive purchase agreement, acceptance and approval by the board
of directors and the shareholders of the seller, satisfactory
completion of legal and financial due diligence, RedHawk obtaining
the required amount of acquisition financing,
and the obtainment of all necessary
consents and approvals of any third parties.
In evaluating forward-looking statements, you should consider
the various factors which may cause actual results to differ
materially from any forward-looking statements including
those listed in the "Risk Factors" section of our latest 10-K
report. Further, the Company may make changes to its
business plans that could or will affect its results. Investors are
cautioned that the Company will undertake no obligation to
update any forward-looking statements.
Klug, Chairman and CFO
Prince, Managing Director